Antihypertensive medication use among recruits for the Trial of Nonpharmacologic Interventions in the Elderly (TONE)

Journal of the American Geriatrics Society

Volumn 44, Issue 10, 1996, Pages 1183-1189

  Espeland, Mark A ^a   Kumanyika, Shiriki ^b   Kostis, John B ^c   Algire, Jenifer ^a   Applegate, William B ^d   Ettinger, Walter ^a   Whelton, Paul K ^e   Bahnson, Judy ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; AGING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; ENZYME INHIBITION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; QUESTIONNAIRE; RACE DIFFERENCE; SCREENING TEST; SEX DIFFERENCE; STATISTICAL ANALYSIS; TREATMENT PLANNING;

EID: 0029839459     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb01367.x     Document Type: Article

References (39)

1. Gross TP, Wise RP, Knapp DE. Antihypertensive drug use: Trends in the United States from 1973 to 1985. Hypertension 1989:13(suppl):I-113-118.
2. Manolio TA, Cutler JA, Furberg CD et al. Trends in pharmacologic management or hypertension in the United States. Arch Intern Med 1995;155:829-837.
3. Psaty BM, Koepsell TD, Yanez ND et al. Temporal patterns of antihypertensive medication use among old adults, 1989 through 1992. JAMA 1995;273:1436-1438.
4. Hume AL, Barbour MM, Willey CJ et al. Changing trends in antihypertensive therapy in two New England communities during the 1980s. Pharmacotherapy 1993;13:244-251.
5. Psaty BM, Savage PJ, Tell GS et al. Temporal patterns of antihypertensive medication use among elderly patients: The Cardiovascular Health Study. JAMA 1993;270:1837-1841.
6. Glynn RJ, Brock DB, Harris T et al. Use of antihypertensive drugs and trends in blood pressure in the elderly. Arch Intern Med 1995;155:1855-1860.
7. IMS America. National Disease and Therapeutic Index. Ambler, PA: IMS American, 1993.
8. Breckenridge MB, Kostis JB. Isolated systolic hypertension in the elderly: Results of a statewide survey of clinical practice in New Jersey. Am J Med 1989;86:370-375.
9. 1988 Joint National Committee. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988;48:1023-1038.
10. National High Blood Pressure Education Program. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993;153:154-183.
11. Laragh JH. Issues, goals, and guidelines in selecting first-line drug therapy for hypertension. Hypertension 1989;13(suppl):I-103-112.
12. Carter BL, Frohlich ED, Elliot WJ et al. Selected factors that influence responses to antihypertensives: Choosing therapy for the uncomplicated patient. Arch Fam Med 1994;3:528-536.
13. USDHHS.PHS.NIH. Diagnosis and Management of Hypertension: A Nationwide Survey of Physician's Knowledge, Attitudes, and Reported Behavior. Final Report. NHLB1 Publication No. 89-2968. September 1989.
14. Appel LJ, Espeland M, Whelton PK et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE): Design and rationale of blood pressure control trial. Ann Epidemiol 1995;5:119-129.
15. Whelton PK, Bahnson J, Appel LJ et al. Recruitment in the Trial of Non-pharmacological Intervention in the Elderly (TONE). J Am Geriatr Soc, 1997, in press.
16. SAS Institute, Inc. SAS/STAT User's Guide, Version 6, 4th Ed., Vol 2. Cary, NC: SAS Institute, Inc., 1989, pp 1071-1126.
17. Abramowicz M, ed. Drugs for hypertension. Med Lett Drug Ther1995;37:45-50.
18. Monane M, Glynn RJ, Gurwitz JH et al. Trends in medication choices for hypertension in the elderly: The decline of rhiazides. Hypertension 1995;25:1045-1051.
19. Deleted in proof
20. Charlson ME, Horwitz RI. Applying results of randomized trials to clinical practice: Impact of losses before randomization. Br Med J 1984;289:1281-1284.
21. Hypertension Detection and Follow-up Program Cooperative Group. Patient participation in a hypertension control program. JAMA 1978;239:1507-1514.
22. Brown KM, Oberman A, Van Natta ML, Forster JL. Baseline characteristics in the Hypertension Prevention Trial. Control Clin Trials 1989;10:40-64S.
23. Troein M, Arneson T, Rastam L et al. Reported treatment of hypertension by family physicians in Sweden and Minnesota: A physician survey of practice habits. J Intern Med 1995;228:215-221.
24. MacMahon S, Cutler J, Brittain E, Higgins M. Obesity and hypertension: Epidemiologie and clinical uses. Eur Heart J 1987;8:57-70.
25. Kostis JB, Berge KG, Davis BR et al. Effect of atenolol and reserpine on selected events in the Systolic Hypertension in the Elderly Program (SHEP). Am J Hypertens 1995;8:1147-1153.
26. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: Principal results. Br Med J 1992;304:405-412.
27. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255-3264.
28. Dahlof B, Hansson L, Lindholm LH et al. Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) analyses performed up to 1992. Clin Exp Hypertens 1993;15:925-939.
29. Hollenberg NK. Evolution of the treatment of hypertension: What really matters in the 1990s? Am J Med 1992;93(2A)4-10S.
30. Gifford RW, Borazanian RA. Traditional first-line therapy: Overview of medical benefits and side effects. Hypertension 1989;13:1-119-124.
31. Zing W, Ferguson RK, Vlasses PH. Calcium antagonists in elderly and black hypertensive patients. Arch Intern Med 1991;151:2154-2162.
32. Jamerson KA. Prevalence of complications and response to different treatments of hypertension in African Americans and white Americans in the US. Clin Exp Hypertens 1993;15:979-995.
33. Tyroler HA. Socioeconomic status in the epidemiology and treatment of hypertension. Hypertension 1989;13(suppl):I-94-97.
34. Murphy MB. Selecting optimum antihypettensive therapy: Indications for choosing a calcium channel blocker. Am J Med 1992;93(2A):38-44S.
35. 2 adrenergic receptors. Hypertension 1995;25:88-91.
36. Kostis JB. The effect of enalapril on mortal and morbid events in patients with hypertension and left ventricular dysfunction. Am J Hypertens 1995;8:909-914.
37. Psaty BM, Heckbert SR, Koepsell TD et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.
38. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: An overview. Br Med J 1989;299:1187-1192.
39. Furberg CD, Psaty BM, Meyer JV. Nifedipine: Dose related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.